Registered entities
Impel Neuropharma, Inc
Reg. No. 001-40353United States
Impel Pharmaceuticals Inc
Reg. No. 263058238United States
IMPEL PHARMACEUTICALS INC
Reg. No. 1445499United States
Innovation
14 patent families (6 granted) — focus: Human necessities; filing pace slowing. Cited 3,337 times.
| Year | Filings |
|---|---|
| 2012 | 2 |
| 2013 | 2 |
| 2014 | 3 |
| 2015 | 2 |
| 2016 | 2 |
| 2017 | 4 |
| 2018 | 3 |
| 2019 | 9 |
| 2020 | 11 |
| 2021 | 11 |
| 2022 | 8 |
| 2023 | 2 |
Investor mix
9 investors on record; lead investors include KKR, Vivo Capital, 5AM Ventures, VenBio; 1 has since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 3 | 33% |
| Private equity | 3 | 33% |
| Angel & family office | 1 | 11% |
| Accelerator & incubator | 1 | 11% |
| Other / undisclosed | 1 | 11% |